Skip to main content

Table 2 Treatment and outcome summary for chordoma patients

From: Chordomas and chondrosarcomas of the skull base: treatment and outcome analysis in a consecutive case series of 24 patients

Patient

Diagnosis

Initial treatment

Adjuvant therapy

Disease recurrence/progression

Further treatment

Survival

Follow-up from initial treatment

1

Clival chordoma

Transnasal endoscopic resection

PBT

Yes

Surgery + stereotactic radiosurgery

Yes

10 years

2

Clival chordoma

Transnasal endoscopic resection

PBT

Yes

Surgery + afatinib

Yes

8 years

3

Clival chordoma

Transnasal endoscopic resection

PBT

Yes

No

No

4 years

4

Clival chordoma

Transnasal endoscopic resection

PBT

Lost to follow-up due to CVA post PBT

-

-

3 years

5

Clival chordoma

Transnasal endoscopic resection

PBT

No

No

Yes

6 years

6

Clival chordoma

Transnasal endoscopic resection

PBT

Yes

Surgery

Yes

4 years

7

Clival Chordoma

Transnasal endoscopic resection

PBT

No

No

Yes

4 years

8

Clival chordoma

Transnasal endoscopic resection

PBT

Yes

Surgery

Yes

4 years

9

Clival chordoma

Transnasal endoscopic resection

PBT

No

No

Yes

3 years (lost to follow-up beyond this)

10

Clival chordoma

Transnasal endoscopic resection

Nil

-

-

-

Lost to follow-up post operatively

11

Clival chordoma

Transnasal endoscopic resection

IMRT

No

No

No unrelated to disease

4 years